CTOs on the Move

Health Care Excel Inc

www.hce.org

 
Health Care Excel Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.hce.org
  • 2629 Waterfront Parkway West Dr Suite 150
    Indianapolis, IN USA 46214
  • Phone: 317.347.4500

Executives

Name Title Contact Details

Similar Companies

TriStar StoneCrest Medical Center

StoneCrest Medical Center offers acute care services including emergency and intensive care, general surgery, cardiology, obstetrics, physical medicine, outpatient diagnostic services and cancer care. From the newest in cardiac ultrasound technology to the state-of-the-art catheterization lab, TriStar StoneCrest is equipped to deliver a range of services to help prevent, treat, and recover from heart disease and stroke. From screenings to diagnostic cardiac catheterization, from angioplasty to rehabilitation, TriStar StoneCrest`s services have earned a reputation for excellence.

St. Andrew's Resources for Seniors

St. Andrew's Resources for Seniors is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. St. Andrew's Resources for Seniors is based in Saint Louis, MO. You can find more information on St. Andrew's Resources for Seniors at www.standrews1.com

Healthcare Informatics Associates

Healthcare Informatics Associates is a Bainbridge Island, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bisco Inc

Bisco Inc is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.